Candidates for Tirzepatide weight loss injections typically include adults with a Body Mass Index (BMI) of 30 or greater
Not approved for diagnostic, therapeutic, or medical applications
We will post our most current Policy on this page with the last updated date, and you should periodically visit this page to review it
In addition to examining exponential changes in weight after GLP-1RA cessation, the researchers also explored reported changes in glycated hemoglobin (HbA1c) levels and systolic blood pressures
3 Move forward with confidence Get monthly weight loss medication with free, discreet shipping and support from the Willow Care Team
In addition, tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and GLP-1 receptors, resulted in even more pronounced weight loss effects, suggesting a potential advantage over traditional GLP-1 RAs